Literature DB >> 18398297

Differences in vaccinations in European Union.

Susanna Esposito1, Nicola Principi.   

Abstract

The European Union (EU) currently has 27 Member States, each with its own history, characteristics and habits. The National Health Services of most of these countries have different vaccination systems, different vaccine recommendations and different schedules of vaccine administration, which means that immunization is not considered in the same way and, at least for some antigens, vaccination coverage does not always meet changing medical needs. Together with a lack of political will concerning prevention in childhood, a poor understanding or false perceptions on the part of the general public (and even healthcare workers), and the inadequacies and heterogeneity of the vaccination systems can all be considered barriers to vaccinations in Europe. The most important limitations are those relating to the evaluation of vaccination coverage, the lack of active reminder systems to pick up patients who miss appointments, and the monitoring of adverse events. A common programme designed to overcome these limitations could be beneficial in promoting vaccinations everywhere, above all because active measures by the Health Authorities to demonstrate the importance they attribute to vaccination could convince still uncertain parents to have their children vaccinated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398297     DOI: 10.4161/hv.4.4.5587

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  2 in total

1.  DTaP(5)-IPV-Hib vaccine (Pediacel®).

Authors:  James E Frampton
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

2.  How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groups.

Authors:  Karine Lungarde; Fanette Blaizeau; Isabelle Auger-Aubin; Daniel Floret; Serge Gilberg; Christine Jestin; Thomas Hanslik; Corinne Le Goaster; Daniel Lévy-Bruhl; Thierry Blanchon; Louise Rossignol
Journal:  BMC Fam Pract       Date:  2013-06-19       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.